Cargando…
Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease
INTRODUCTION: Autonomic disorders have been recognized as important Parkinson’s disease (PD) components. Some vulnerable structures are related to the central autonomic network and have also been linked to autonomic function alterations. The aims of the study are to evaluate the severity of the auto...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462903/ https://www.ncbi.nlm.nih.gov/pubmed/28642732 http://dx.doi.org/10.3389/fneur.2017.00246 |
_version_ | 1783242591921242112 |
---|---|
author | Lin, Wei-Che Chen, Pei-Chin Huang, Chih-Cheng Tsai, Nai-Wen Chen, Hsiu-Ling Wang, Hung-Chen Chou, Kun-Hsien Chen, Meng-Hsiang Chen, Yi-Wen Lu, Cheng-Hsien |
author_facet | Lin, Wei-Che Chen, Pei-Chin Huang, Chih-Cheng Tsai, Nai-Wen Chen, Hsiu-Ling Wang, Hung-Chen Chou, Kun-Hsien Chen, Meng-Hsiang Chen, Yi-Wen Lu, Cheng-Hsien |
author_sort | Lin, Wei-Che |
collection | PubMed |
description | INTRODUCTION: Autonomic disorders have been recognized as important Parkinson’s disease (PD) components. Some vulnerable structures are related to the central autonomic network and have also been linked to autonomic function alterations. The aims of the study are to evaluate the severity of the autonomic dysfunction and the cortical hypoperfusion using arterial spin labeling (ASL) MRI. And then, possible relationships of significant between-group differences in perfusion pattern to clinical variables and autonomic functions were examined to determine the pharmaceutical effects of dopaminergic treatment on cerebral blood flow (CBF) in patients with PD. METHODS: Brain ASL MRI was carried out in 20 patients with PD (6 men and 14 women, mean age: 63.3 ± 6.4 years) and 22 sex- and age-matched healthy volunteers to assess whole-brain CBF and the effects of dopaminergic therapy on perfusion. All subjects underwent a standardized evaluation of cardiovagal and adrenergic function including a deep breathing, Valsalva maneuver, and 5-min head-up tilt test. Perfusion MRI data were acquired on a 3.0 T scanner with a pulsed continuous ASL technique. The CBF, autonomic parameters, and clinical data were analyzed after adjusting for age and sex. RESULTS: Patients exhibited a decline in autonomic function (rapid heart rate in response to deep breathing, low baroreflex sensitivity, high systolic and diastolic pressure, and altered tilting test response), widespread low CBF, and robust response to dopaminergic therapy. Lower perfusion in the middle frontal gyrus was associated with increased clinical disease severity (Unified Parkinson’s Disease Rating Scale I score, P < 0.001). Lower perfusion in autonomic control areas, such as the frontal lobe and insula, were significantly associated with autonomic impairment (P < 0.001). CONCLUSIONS: Our study indicates that PD is a progressive neurodegenerative disorder that changes the perfusion of central nervous system and is associated with variable autonomic dysfunctions. Neuronal loss and sympathetic activation may explain the interaction between cortical autonomic region perfusion and cardiovascular autonomic function. |
format | Online Article Text |
id | pubmed-5462903 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54629032017-06-22 Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease Lin, Wei-Che Chen, Pei-Chin Huang, Chih-Cheng Tsai, Nai-Wen Chen, Hsiu-Ling Wang, Hung-Chen Chou, Kun-Hsien Chen, Meng-Hsiang Chen, Yi-Wen Lu, Cheng-Hsien Front Neurol Neuroscience INTRODUCTION: Autonomic disorders have been recognized as important Parkinson’s disease (PD) components. Some vulnerable structures are related to the central autonomic network and have also been linked to autonomic function alterations. The aims of the study are to evaluate the severity of the autonomic dysfunction and the cortical hypoperfusion using arterial spin labeling (ASL) MRI. And then, possible relationships of significant between-group differences in perfusion pattern to clinical variables and autonomic functions were examined to determine the pharmaceutical effects of dopaminergic treatment on cerebral blood flow (CBF) in patients with PD. METHODS: Brain ASL MRI was carried out in 20 patients with PD (6 men and 14 women, mean age: 63.3 ± 6.4 years) and 22 sex- and age-matched healthy volunteers to assess whole-brain CBF and the effects of dopaminergic therapy on perfusion. All subjects underwent a standardized evaluation of cardiovagal and adrenergic function including a deep breathing, Valsalva maneuver, and 5-min head-up tilt test. Perfusion MRI data were acquired on a 3.0 T scanner with a pulsed continuous ASL technique. The CBF, autonomic parameters, and clinical data were analyzed after adjusting for age and sex. RESULTS: Patients exhibited a decline in autonomic function (rapid heart rate in response to deep breathing, low baroreflex sensitivity, high systolic and diastolic pressure, and altered tilting test response), widespread low CBF, and robust response to dopaminergic therapy. Lower perfusion in the middle frontal gyrus was associated with increased clinical disease severity (Unified Parkinson’s Disease Rating Scale I score, P < 0.001). Lower perfusion in autonomic control areas, such as the frontal lobe and insula, were significantly associated with autonomic impairment (P < 0.001). CONCLUSIONS: Our study indicates that PD is a progressive neurodegenerative disorder that changes the perfusion of central nervous system and is associated with variable autonomic dysfunctions. Neuronal loss and sympathetic activation may explain the interaction between cortical autonomic region perfusion and cardiovascular autonomic function. Frontiers Media S.A. 2017-06-08 /pmc/articles/PMC5462903/ /pubmed/28642732 http://dx.doi.org/10.3389/fneur.2017.00246 Text en Copyright © 2017 Lin, Chen, Huang, Tsai, Chen, Wang, Chou, Chen, Chen and Lu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Lin, Wei-Che Chen, Pei-Chin Huang, Chih-Cheng Tsai, Nai-Wen Chen, Hsiu-Ling Wang, Hung-Chen Chou, Kun-Hsien Chen, Meng-Hsiang Chen, Yi-Wen Lu, Cheng-Hsien Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease |
title | Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease |
title_full | Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease |
title_fullStr | Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease |
title_full_unstemmed | Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease |
title_short | Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease |
title_sort | autonomic function impairment and brain perfusion deficit in parkinson’s disease |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462903/ https://www.ncbi.nlm.nih.gov/pubmed/28642732 http://dx.doi.org/10.3389/fneur.2017.00246 |
work_keys_str_mv | AT linweiche autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease AT chenpeichin autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease AT huangchihcheng autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease AT tsainaiwen autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease AT chenhsiuling autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease AT wanghungchen autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease AT choukunhsien autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease AT chenmenghsiang autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease AT chenyiwen autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease AT luchenghsien autonomicfunctionimpairmentandbrainperfusiondeficitinparkinsonsdisease |